IBDEI075 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,3029,1,3,0)
 ;;=3^Diabetes Type 2 w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,3029,1,4,0)
 ;;=4^E11.621
 ;;^UTILITY(U,$J,358.3,3029,2)
 ;;=^5002656
 ;;^UTILITY(U,$J,358.3,3030,0)
 ;;=E11.44^^18^213^8
 ;;^UTILITY(U,$J,358.3,3030,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3030,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Amyotrophy
 ;;^UTILITY(U,$J,358.3,3030,1,4,0)
 ;;=4^E11.44
 ;;^UTILITY(U,$J,358.3,3030,2)
 ;;=^5002648
 ;;^UTILITY(U,$J,358.3,3031,0)
 ;;=E11.59^^18^213^7
 ;;^UTILITY(U,$J,358.3,3031,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3031,1,3,0)
 ;;=3^Diabetes Type 2 w/ Circulatory Complications
 ;;^UTILITY(U,$J,358.3,3031,1,4,0)
 ;;=4^E11.59
 ;;^UTILITY(U,$J,358.3,3031,2)
 ;;=^5002652
 ;;^UTILITY(U,$J,358.3,3032,0)
 ;;=E11.638^^18^213^25
 ;;^UTILITY(U,$J,358.3,3032,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3032,1,3,0)
 ;;=3^Diabetes Type 2 w/ Oral Complications
 ;;^UTILITY(U,$J,358.3,3032,1,4,0)
 ;;=4^E11.638
 ;;^UTILITY(U,$J,358.3,3032,2)
 ;;=^5002660
 ;;^UTILITY(U,$J,358.3,3033,0)
 ;;=E11.628^^18^213^27
 ;;^UTILITY(U,$J,358.3,3033,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3033,1,3,0)
 ;;=3^Diabetes Type 2 w/ Skin Complications
 ;;^UTILITY(U,$J,358.3,3033,1,4,0)
 ;;=4^E11.628
 ;;^UTILITY(U,$J,358.3,3033,2)
 ;;=^5002658
 ;;^UTILITY(U,$J,358.3,3034,0)
 ;;=E11.630^^18^213^26
 ;;^UTILITY(U,$J,358.3,3034,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3034,1,3,0)
 ;;=3^Diabetes Type 2 w/ Periodontal Disease
 ;;^UTILITY(U,$J,358.3,3034,1,4,0)
 ;;=4^E11.630
 ;;^UTILITY(U,$J,358.3,3034,2)
 ;;=^5002659
 ;;^UTILITY(U,$J,358.3,3035,0)
 ;;=E11.8^^18^213^28
 ;;^UTILITY(U,$J,358.3,3035,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3035,1,3,0)
 ;;=3^Diabetes Type 2 w/ Unspec Complications
 ;;^UTILITY(U,$J,358.3,3035,1,4,0)
 ;;=4^E11.8
 ;;^UTILITY(U,$J,358.3,3035,2)
 ;;=^5002665
 ;;^UTILITY(U,$J,358.3,3036,0)
 ;;=E11.9^^18^213^29
 ;;^UTILITY(U,$J,358.3,3036,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3036,1,3,0)
 ;;=3^Diabetes Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,3036,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,3036,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,3037,0)
 ;;=E11.36^^18^213^9
 ;;^UTILITY(U,$J,358.3,3037,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3037,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Cataract
 ;;^UTILITY(U,$J,358.3,3037,1,4,0)
 ;;=4^E11.36
 ;;^UTILITY(U,$J,358.3,3037,2)
 ;;=^5002642
 ;;^UTILITY(U,$J,358.3,3038,0)
 ;;=E11.22^^18^213^10
 ;;^UTILITY(U,$J,358.3,3038,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3038,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Chronic Kidney Disease
 ;;^UTILITY(U,$J,358.3,3038,1,4,0)
 ;;=4^E11.22
 ;;^UTILITY(U,$J,358.3,3038,2)
 ;;=^5002630
 ;;^UTILITY(U,$J,358.3,3039,0)
 ;;=E11.29^^18^213^12
 ;;^UTILITY(U,$J,358.3,3039,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3039,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Kidney Complication
 ;;^UTILITY(U,$J,358.3,3039,1,4,0)
 ;;=4^E11.29
 ;;^UTILITY(U,$J,358.3,3039,2)
 ;;=^5002631
 ;;^UTILITY(U,$J,358.3,3040,0)
 ;;=E11.21^^18^213^13
 ;;^UTILITY(U,$J,358.3,3040,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3040,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Nephropathy
 ;;^UTILITY(U,$J,358.3,3040,1,4,0)
 ;;=4^E11.21
 ;;^UTILITY(U,$J,358.3,3040,2)
 ;;=^5002629
 ;;^UTILITY(U,$J,358.3,3041,0)
 ;;=E11.39^^18^213^16
 ;;^UTILITY(U,$J,358.3,3041,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3041,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Ophthalmic Complication
 ;;^UTILITY(U,$J,358.3,3041,1,4,0)
 ;;=4^E11.39
 ;;^UTILITY(U,$J,358.3,3041,2)
 ;;=^5002643
 ;;^UTILITY(U,$J,358.3,3042,0)
 ;;=E11.311^^18^213^20
 ;;^UTILITY(U,$J,358.3,3042,1,0)
 ;;=^358.31IA^4^2
